Nov 29 (Reuters) - Immunomedics Inc
* Venbio responds to Immunomedics' postponement of annual meeting
* Venbio Select Advisor says is the beneficial owner of about 9 percent of Immunomedics
* Venbio select advisor on Immunomedics' postponement of meeting "considering all options for protecting stockholders' rights under applicable law"
* Venbio Select Advisor says has put forth four director nominees Source text for Eikon: Further company coverage: